---
id: idsa-skin-soft-tissue-2024
title: "IDSA 2024 Clinical Practice Guideline Update: Diagnosis and Management of Skin and Soft Tissue Infections"
short_title: "IDSA SSTI 2024"

organization: Infectious Diseases Society of America
collaborators: null
country: US
url: https://www.idsociety.org/guidelines/
doi: null
pmid: null
open_access: true

specialty: infectious-disease
guideline_type: clinical-practice
evidence_system: IDSA GRADE
conditions:
  - cellulitis
  - abscess
  - skin and soft tissue infection
  - necrotizing fasciitis
tags:
  - MRSA
  - incision and drainage
  - TMP-SMX
  - cephalosporins
  - surgical debridement

publication_date: 2024-08-01
previous_version_date: 2014-06-01
status: current
supersedes: null
superseded_by: null

pdf_path: null
has_pdf: false
last_reviewed: 2025-12-24
---

## Scope
2024 IDSA guideline update on the diagnosis and management of skin and soft tissue infections (SSTIs) in adults and children.

## Key Recommendations

### Classification
- **Purulent SSTIs**: Abscess, furuncle, carbuncle. Usually S. aureus (including MRSA).
- **Non-Purulent SSTIs**: Cellulitis, erysipelas. Usually β-hemolytic streptococci.
- **Necrotizing Infections**: Necrotizing fasciitis, Fournier gangrene. Surgical emergency.

### Abscess
- **Primary Treatment**: Incision and drainage (I&D).
- **Antibiotics**: Add antibiotics for abscesses with:
  - Associated cellulitis, systemic signs of infection (fever, tachycardia), immunocompromise, or failure to improve after I&D.
- **Antibiotic Choice (Purulent/MRSA Coverage)**: TMP-SMX, doxycycline, or clindamycin.

### Cellulitis (Non-Purulent)
- Cover β-hemolytic streptococci.
- **Mild**: Oral cephalexin, dicloxacillin, or amoxicillin-clavulanate.
- **Moderate (Systemic Signs)**: IV cefazolin or nafcillin.
- **MRSA Coverage**: Add if purulence, failed initial therapy, or risk factors. Use TMP-SMX, doxycycline, vancomycin, or daptomycin.

### Necrotizing Fasciitis
- **Surgical Emergency**: Early and aggressive surgical debridement is life-saving.
- **Broad-Spectrum Antibiotics**: Vancomycin + piperacillin-tazobactam (or carbapenem) + clindamycin (for toxin suppression).
- Obtain cultures; adjust therapy based on results.

### Recurrent SSTIs
- Decolonization strategies for recurrent S. aureus infections: chlorhexidine washes, mupirocin nasal ointment.
- Evaluate for underlying risk factors (diabetes, lymphedema, venous insufficiency).

### Duration
- Typically 5-7 days for uncomplicated SSTIs; longer for severe or slow-responding infections.
